Items Tagged ‘neuroendocrine tumors’

August 10th, 2015

Afinitor® Promising in Neuroendocrine Tumors Originating in Gastrointestinal Tract or Lungs

By

The drug Afinitor® (everolimus) is currently be studied in a Phase III clinical trial for patients with nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract or lungs. The trial is ongoing, but findings so far are promising: patients treated with Afinitor plus best supportive care appear to live longer without cancer progression than patients […]

View full entry

Tags: afinitor, everolimus, Gastric Cancer, General Lung Cancer, Lung Cancer, mtor, NET, neuroendocrine tumors, News, Recurrent Gastric Cancer, Stages III-IV Gastric Cancer


May 26th, 2015

Somatuline® Depot

By

Class: Biological Therapy Generic Name: Lanreotide Trade Name: Somatuline® Depot For which conditions is this drug approved? Somatuline Depot is approved for: The long-term treatment of people with acromegaly, a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. Somatuline Depot can be used in these patients when surgery […]

View full entry

Tags: acromegaly, Biological Therapy, Drug Dictionary, neuroendocrine tumors, S, somatostatin